These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 10426994)

  • 1. An activating immunoreceptor complex formed by NKG2D and DAP10.
    Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
    Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells.
    Upshaw JL; Arneson LN; Schoon RA; Dick CJ; Billadeau DD; Leibson PJ
    Nat Immunol; 2006 May; 7(5):524-32. PubMed ID: 16582911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
    Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
    Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
    Fikri Y; Nyabenda J; Content J; Huygen K
    Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells.
    Wu J; Cherwinski H; Spies T; Phillips JH; Lanier LL
    J Exp Med; 2000 Oct; 192(7):1059-68. PubMed ID: 11015446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.
    Billadeau DD; Upshaw JL; Schoon RA; Dick CJ; Leibson PJ
    Nat Immunol; 2003 Jun; 4(6):557-64. PubMed ID: 12740575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of NK cell function by NKG2D modulation in NOD mice.
    Ogasawara K; Hamerman JA; Hsin H; Chikuma S; Bour-Jordan H; Chen T; Pertel T; Carnaud C; Bluestone JA; Lanier LL
    Immunity; 2003 Jan; 18(1):41-51. PubMed ID: 12530974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
    Garrity D; Call ME; Feng J; Wucherpfennig KW
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7641-6. PubMed ID: 15894612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKG2D splice variants: a reexamination of adaptor molecule associations.
    Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
    Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
    J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse.
    Giurisato E; Cella M; Takai T; Kurosaki T; Feng Y; Longmore GD; Colonna M; Shaw AS
    Mol Cell Biol; 2007 Dec; 27(24):8583-99. PubMed ID: 17923698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
    Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
    Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.
    Sutherland CL; Chalupny NJ; Cosman D
    Immunol Rev; 2001 Jun; 181():185-92. PubMed ID: 11513139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.